Stay updated on Sitravatinib Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Advanced NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe site revision changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide NIH notice about updated terminology during a transition appears above the ClinicalTrials.gov page.SummaryDifference1%

- Check18 days agoChange DetectedThe ClinicalTrials.gov page continues to show a 403 Forbidden error. Its footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record. Previously visible trial details and related navigation are no longer accessible and have been replaced by the error screen.SummaryDifference21%

- Check67 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a newer build of the page. It represents a cosmetic update to the page's version label rather than a change to the study data or layout.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.